Insulin treatment, acute or chronic, does not alter the number of CHT proteins at the cell surface, their binding affinity or the maximal uptake of choline. by Katherine J. Fishwick (768451)

Subjects:

Cell surface CHT levels are unchanged by altered PI3-Kinase signaling in non-depolarized cells. by Katherine J. Fishwick (768451)

Subjects:

Dynamics of CHT trafficking are altered by LY294002 treatment. by Katherine J. Fishwick (768451)

Subjects:

Dynamics of CHT internalization are altered by acute insulin treatment. by Katherine J. Fishwick (768451)

Subjects:

Treatment with NaOH decreases ubiquitination of D_4.2R WT and D_{4.2 4KR}R mutant. by Kamila Skieterska (841014)

Less Iso-induced decrease of APD₉₀ in female hearts. by Gregory S. Hoeker (650231)

“…B) Summary data for the decrease in APD₉₀ (versus baseline values) as a function of the dose of Iso (1, 10, 31.6, 100, 316.2 nM) in the LV base (left) and apex of female (n = 5) and male (n = 5) hearts during pacing at 3 Hz (<i>top</i>) and 5.5 Hz (<i>bottom</i>). …”

Cardamonin decreased the expression of lipogenic proteins. by Peiguang Niu (17044532)

A DNA-PKcs-specific inhibitor decreases HBoV1 infection of HAE-ALI. by Xuefeng Deng (138723)

Recovery coefficient. by Masakazu Tsujimoto (22339504)

Subjects:

Results of dose linearity. by Masakazu Tsujimoto (22339504)

Subjects:

Evaluation index results for the JS-10 phantom. by Masakazu Tsujimoto (22339504)

Subjects:

NEMA IEC body phantom. by Masakazu Tsujimoto (22339504)

Subjects:

Relationship between contrast, noise, and CNR. by Masakazu Tsujimoto (22339504)

Subjects:

JS-10 phantom. by Masakazu Tsujimoto (22339504)

Subjects:

The raw data used for the analyses in this study. by Masakazu Tsujimoto (22339504)

Subjects:

Decreasing ShcA expression enhances TGF-β-induced Smad signaling. by Baby Periyanayaki Muthusamy (838234)

“…The error bars show standard error of the mean, based on three independent experiments. Supplemental data are shown in <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.1002325#pbio.1002325.s006" target="_blank">S5 Fig</a> and <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.1002325#pbio.1002325.s001" target="_blank">S1 Data</a>.…”

The Immunologic Effects of Mesalamine in Treated HIV-Infected Individuals with Incomplete CD4+ T Cell Recovery: A Randomized Crossover Trial by Ma Somsouk (283498)

“…The effect of mesalamine in HIV-infected individuals, who exhibit abnormal mucosal immune activation and microbial translocation (MT), has not been established in a placebo-controlled trial. We randomized 33 HIV-infected subjects with CD4 counts <350 cells/mm³ and plasma HIV RNA levels <40 copies/ml on antiretroviral therapy (ART) to add mesalamine vs. placebo to their existing regimen for 12 weeks followed by a 12 week crossover to the other arm. …”

Percentage decrease in model output peak with the administration of exogenous estrogen/progesterone. by Brenda Lyn A. Gavina (15285185)

Reduction of Tks5 expression in tumor cells is associated with decreased angiogenesis. by Barbara Blouw (715467)

The decrease of C/EBPα protein during apoptosis involves induction of protein degradation and inhibition of transcription. by Meng Zhao (54299)

“…<p>(A) After pretreatment with 25 nM of NSC606985 or 0.5 µM of etoposide for 12 hours, NB4 cells were incubated with 10 µg/ml CHX for indicated hours. …”